Fast-acting virus targets melanoma in mice

June 17, 2013 by Bill Hathaway
Fast-acting virus targets melanoma in mice
The green color shows where the vesicular stomatitis virus has infected rust-colored melanoma tumor cells after injection of the virus into the blood stream. The surrounding non-cancerous tissue is free of virus.

(Medical Xpress)—Yale researchers eradicated most melanoma tumors by exposing them to a fast-acting virus, they report in the June 15 edition of the Journal of Virology.

Melanoma is the deadliest type of and can spread throughout the body and even into the brain.

"After injection into the blood stream of mice, the virus finds melanoma on its own, and is fast and aggressive with tumors," said Anthony N. van den Pol, professor of neurosurgery at Yale School of Medicine, investigator for the Yale Cancer Center and senior author of the study. "Because the virus replicates rapidly, it can kill the melanoma before the immune system responds and kills the virus."

In the process of eliminating the virus, the immune system may also begin to target and kill , he added.

The researchers used the —part of a family of viruses that include rabies and may generate flu-like symptoms in humans. The fast-acting virus ignored healthy melanocytes (the cells from which melanoma arises) but zeroed in on 19 melanoma tumors studied. In 70 percent of tumors tested, melanoma was eradicated completely, while the rest showed a more limited response to the virus.

If safety of the virus can be substantiated, the next target would be to begin trials in humans, van den Pol said.

Explore further: Virus kills melanoma in animal model, spares normal cells

More information: jvi.asm.org/content/87/2/1019.full

Related Stories

Virus kills melanoma in animal model, spares normal cells

April 23, 2013
Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, ...

Researchers building melanoma vaccine to combat skin cancer

March 19, 2012
Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...

Study reveals trigger that may speed melanoma growth

March 28, 2012
(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.

Novel Amgen virus-vaccine shrinks melanoma tumors

March 20, 2013
Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.

Diabetes drug points the way to overcoming drug resistance in melanoma

June 11, 2013
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.